Publicaties

Long Term Follow Up of Bridging Stents is Necessary! Van den Eynde W, Smet N.
Eur J Vasc Endovasc Surg. 2026 Jan 20:S1078-5884(26)00059-6.
An International Expert-Based CONsensus on Indications and Techniques for aoRtic balloOn occLusion in the Management of Ruptured Abdominal Aortic Aneurysms (CONTROL-RAAA). D’Oria M, Lembo R, Hörer TM, Rasmussen T, Mani K, Parlani G, Ierardi AM, Veraldi GF, Melloni A, Bonardelli S, Lepidi S, Bertoglio L; Collaborative CONTROL-RAAA Study Group.
J Endovasc Ther. 2025 Oct;32(5):1623-1633. doi: 10.1177/15266028231217233.
International Expert Consensus on the Management of Acute Aortic Type B Intramural Haematoma and Penetrating Ulcer. Francesco Squizzato, Mario D’Oria, Michele Antonello, Santi Trimarchi, Kevin Mani, Andrew Holden, Tilo Kölbel, Stephan Haulon, Eric Verhoeven, Dittmar Böckler, Tim Resch, Ali Azizzadeh, Joseph Lombardi, Michele Piazza; IDEAAS-IMH/PAU Investigators. Eur J Vasc Endovasc Surg 2025 Sep 30:S1078-5884(25)00933-5. doi: 10.1016/j.ejvs.2025.09.045.

Spontaneous rupture of an aneurysm of the right subclavian artery as a first presentation of Ehlers Danlos syndrome in a 15-year old boy.
Verbert A, Verbist J, Peeters P, Deferm H, Haenen L.
Acta Chir Belg. 2013 Sep-Oct;113(5):367-72.

Dysphagia lusoria. Indications and surgical approaches for non-aneurysmatic aberrant right subclavian artery. 
Debonnaire G, Verbist J, Peeters P. 
Acta Chir Belg. 2012 May-Jun;112(3):237-9.

The role of carotid artery stenting for recent cerebral ischemia.
Bosiers M, Callaert J, Deloose K, Verbist J, Keirse K, Peeters P.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):293-304.

Carotid stenting is a valuable alternative to carotid endarterectomy.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2008 Dec;49(6):709-19.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Verbist J, Peeters P.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

The impact of embolic protection device and stent design on the outcome of CAS.
Bosiers M, Deloose K, Verbist J, Peeters P.
Perspect Vasc Surg Endovasc Ther. 2008 Sep;20(3):272-9.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Peeters P, Verbist J.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

Does free cell area influence the outcome in carotid artery stenting?
Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F, Cremonesi A, Setacci C.
Eur J Vasc Endovasc Surg. 2007 Feb;33(2):135-41

Do device characteristics impact outcome in carotid artery stenting?
Hart JP, Peeters P, Verbist J, Deloose K, Bosiers M.
J Vasc Surg. 2006 Oct;44(4):725-30.

Review of stents for the carotid artery.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):107-13.

Carotid artery stenting: which stent for which lesion?
Bosiers M, Deloose K, Verbist J, Peeters P.
Vascular. 2005 Jul-Aug;13(4):205-10.

Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry).
Bosiers M, Peeters P, Deloose K, Verbist J, Sievert H, Sugita J, Castriota F, Cremonesi A.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):241-7.

Endovascular treatment strategies for supra-aortic arterial occlusive disease.
Peeters P, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):193-200.

Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting.
Bosiers M, Peeters P, Deloose K, Verbist J, Sprouse RL 2nd.
Vascular. 2005 Mar-Apr;13(2):92-7.

Choice of protection devices in carotid angioplasty. Two case reports.
Hendrickx T, Verbist J, Peeters P.
Acta Chir Belg. 2004 Jun;104(3):357-60.

Infective native aneurysms of the femoropopliteal arteries: A systematic review and pooled analysis.
Nick Smet, Xavier Berard, Oskar Ljungquist, Pim van den Hoven, Karl Sorelius.
J Vasc Surg 2025 Aug 18:S0741-5214(25)01605-2. doi: 10.1016/j.jvs.2025.08.012.

A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesions.
Deloose K, Gielis J, Maene L, Lansink W, Lerut P, Verbist J, Keirse K, Goverde P, Vercauteren S, Callaert J.
J Cardiovasc Surg (Torino). 2025 Feb;66(1):37-45.

Two-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.
Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, VAN DEN Eynde W, Maene L, Beelen R, Keirse K, Hendriks J, Callaert J, Bosiers M.
J Cardiovasc Surg (Torino). 2024 Dec;65(6):509-514. doi: 10.23736/S0021-9509.24.12920-5. Epub 2024 Dec 10.
 
ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year Results.
Bosiers MJ, De Donato G, Torsello G, Silveira PG, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Eckstein HH, Teβarek J, Giaquinta A, Van den Eynde W, Verbist J, Callaert J, Deloose K, Bosiers M.
Cardiovasc Intervent Radiol. 2023 Oct;46(10):1348-1358. doi: 10.1007/s00270-023-03549-0. Epub 2023 Sep 5.
 

ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.
Bosiers M, DE Donato G, Torsello G, Galvagni Silveira P, Deloose K, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Callaert J, Eckstein HH, Tessarek J, Giaquinta A, van den Eynde W, Verbist J, Wahl-Gravsen J, Bosiers MJ.
J Cardiovasc Surg (Torino). 2023 Aug;64(4):413-421. doi: 10.23736/S0021-9509.23.12607-3. Epub 2023 May 10.

One-year outcome of the everolimus eluting balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients. 
Taeymans K, Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Van den Eynde W, Torsello G, Wauters J.
J Cardiovascu Surg (Torino). 2020 Aug; 61 (4): 445-450

One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Hendriks J, Callaert J, Bosiers M, Wauters J.
J Cardiovasc Surg (Torino). 2020 Aug;61(4):471-477. doi: 10.23736/S0021-9509.20.11236-9. Epub 2020 Apr 1.

EVOLUTION Study: 12-month results.
Bosiers M, Deloose K, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Wauters J.
J Cardiovasc Surg (Torino). 2019 Aug;60(4):490-495. doi: 10.23736/S0021-9509.19.10706-9. Epub 2019 Jan 28.

BeGraft Peripheral PMCF Study: 12-month results.
Deloose K, Bosiers M, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K.
J Cardiovasc Surg (Torino). 2017 May 26

24-Month Data from the Bravissimo: A Large-scale Prospective Registry on iliac Stenting for TASC A & B and TASC C & D Lesions.
de Donato G, Bosiers M, Setacci F, Deloose K, Galzerano G, Verbist J, Peeters P, Setacci C.
Ann Vasc Surg. 2015;29(4):738-50

IVUS is not worth the cost for peripheral arterial disease interventions.
D Struyve, W Van den Eynde, J Verbist, P Peeters.
CX 14 Vascular and endovascular Challenges Update, Apr 2015.

Primary stenting is nowadays the golden standard treatment for TASC II A & B iliac lesions: The definitive MISAGO 1-year results.
Deloose K, Bosiers M, Callaert J, Verbist J, Vermassen F, Scheinert D, Torsello G, Peeters P.
J Cardiovasc Surg (Torino). 2014 Oct 21.

Popliteal artery aneurysm: when open, when endo?
Gallala S, Verbist J, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Apr;55(2 Suppl 1):239-47

Which is currently the best strategy for treatment of SFA in-stent restenosis?
Elens M, Verbist J, Keirse K, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Aug;55(4):477-81.

Refining stent technologies for femoral interventions.
Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2012 Aug;53(4):465-73.

Endovascular procedures and new insights in diabetic limb salvage.
Peeters P, Verbist J, Keirse K, Callaert J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2012 Feb;53(1):31-7.

Results of the Protégé Everflex 200 mm long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P.
J Vasc Surg. 2011 Oct;54(4):1042-50.

Drug eluting stents below the knee.
Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2011 Apr;52(2):231-4

Prevention and treatment of in-stent restenosis.
Bosiers M, Deloose K, Keirs K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2010 Aug;51(4):591-8.

Endovascular management of acute limb ischemia.
Peeters P, Verbist J, Keirse K, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):329-36.

Are drug-eluting stents the future of SFA treatment?
Bosiers M, Deloose K, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2010 Feb;51(1):115-9.

What is involved in offering an acute endovascular service?
Patrick Peeters, MD, Ozan Yazar, MD, Wouter Van den Eynde, MD, Jürgen Verbist, MD, Koen De Loose, MD, Marc Bosiers, MD.
Vascular and Endovascular Controversies Update, Charing Cross, 2010

Other endovascular methods of treating the diabetic foot.
Peeters P, Keirse K, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2009 Jun;50(3):313-21.

Update management below knee intervention.
Bosiers M, Deloose K, Verbist J, Peeters P.
Minerva Cardioangiol. 2009 Feb;57(1):117-29.

Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2008 Apr;49(2):159-65.

Will heparin-bonded PTFE replace autologous venous conduits in infrapopleal bypass?
Peeters P, Verbist J, Bosiers M, Deloose K.
Italian Journal of Vascular and Endovascular Surgery 15(3):143-148 September 2008.

Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses.
Peeters P, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):407-13.

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.
Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P.
Vascular. 2006 Mar-Apr;14(2):63-9.

Will absorbable metal stent technology change our practice?
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):393-7.

Percutaneous transluminal angioplasty for treatment of ”below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):171-6.

Preliminary results after application of absorbable metal stents in patients with critical limb ischemia.
Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B.
J Endovasc Ther. 2005 Feb;12(1):1-5.

Durability and efficacy of the ELVeS® Radial® 2ring slim fiber for multiple ablations.
Verbist J, Laeremans V, Gryffroy F, Van den Eynde W, Heerinckx C, Haesen D.Phlebology. 2023 Aug 6.

Right sided Cockett’s Syndrome. 
Du Pont B, Verbist J, Van den Eynde W, Peeters P.
Acta Chir Belg. 2016 Apr;116(2):114-8.